Internal Medicine Journal
@the-imj.bsky.social
The Internal Medicine Journal is the official peer-reviewed publication of the Adult Medicine Division at the Royal Australasian College of Physicians. bit.ly/IntMedJ
Pinned
IMJ November (Vol 55, Iss 11) is now online
bit.ly/47HoPbI
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
bit.ly/47HoPbI
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ November 2025 #OpenAccess
Clinical Perspective: Narcolepsy 2025 bit.ly/4nK4s3Z
Narcolepsy is a rare disorder of central hypersomnolence which significantly impacts affected individuals. This article reviews the current landscape of narcolepsy in Australasia.
@theracp.bsky.social
Clinical Perspective: Narcolepsy 2025 bit.ly/4nK4s3Z
Narcolepsy is a rare disorder of central hypersomnolence which significantly impacts affected individuals. This article reviews the current landscape of narcolepsy in Australasia.
@theracp.bsky.social
November 17, 2025 at 3:00 AM
IMJ November 2025 #OpenAccess
Clinical Perspective: Narcolepsy 2025 bit.ly/4nK4s3Z
Narcolepsy is a rare disorder of central hypersomnolence which significantly impacts affected individuals. This article reviews the current landscape of narcolepsy in Australasia.
@theracp.bsky.social
Clinical Perspective: Narcolepsy 2025 bit.ly/4nK4s3Z
Narcolepsy is a rare disorder of central hypersomnolence which significantly impacts affected individuals. This article reviews the current landscape of narcolepsy in Australasia.
@theracp.bsky.social
IMJ November 2025 #FreeAccess
Review: Immune checkpoint inhibitor therapy bit.ly/4nEQzUo
As survival rates for cancer improve, a new class of treatment complication, immune related adverse events (irAEs) has emerged.
@theracp.bsky.social
Review: Immune checkpoint inhibitor therapy bit.ly/4nEQzUo
As survival rates for cancer improve, a new class of treatment complication, immune related adverse events (irAEs) has emerged.
@theracp.bsky.social
November 16, 2025 at 3:00 AM
IMJ November 2025 #FreeAccess
Review: Immune checkpoint inhibitor therapy bit.ly/4nEQzUo
As survival rates for cancer improve, a new class of treatment complication, immune related adverse events (irAEs) has emerged.
@theracp.bsky.social
Review: Immune checkpoint inhibitor therapy bit.ly/4nEQzUo
As survival rates for cancer improve, a new class of treatment complication, immune related adverse events (irAEs) has emerged.
@theracp.bsky.social
IMJ November 2025 #FreeAccess
Editorial: Measuring clinical activities and outcomes for Gen Med
bit.ly/3LrBxUI
@theracp.bsky.social
Editorial: Measuring clinical activities and outcomes for Gen Med
bit.ly/3LrBxUI
@theracp.bsky.social
November 15, 2025 at 3:00 AM
IMJ November 2025 #FreeAccess
Editorial: Measuring clinical activities and outcomes for Gen Med
bit.ly/3LrBxUI
@theracp.bsky.social
Editorial: Measuring clinical activities and outcomes for Gen Med
bit.ly/3LrBxUI
@theracp.bsky.social
IMJ November 2025 #OpenAccess
Editor's Choice (Original Article): What does “complex” mean for the general medicine team?
bit.ly/47IAvem
@theracp.bsky.social
Editor's Choice (Original Article): What does “complex” mean for the general medicine team?
bit.ly/47IAvem
@theracp.bsky.social
November 14, 2025 at 3:00 AM
IMJ November 2025 #OpenAccess
Editor's Choice (Original Article): What does “complex” mean for the general medicine team?
bit.ly/47IAvem
@theracp.bsky.social
Editor's Choice (Original Article): What does “complex” mean for the general medicine team?
bit.ly/47IAvem
@theracp.bsky.social
IMJ November (Vol 55, Iss 11) is now online
bit.ly/47HoPbI
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
bit.ly/47HoPbI
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
November 13, 2025 at 2:12 AM
IMJ November (Vol 55, Iss 11) is now online
bit.ly/47HoPbI
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
bit.ly/47HoPbI
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ October 2025 #FreeAccess
Original Article: Post-transplant lymphoproliferative disorder in liver transplant
bit.ly/46TttD9
@theracp.bsky.social
Original Article: Post-transplant lymphoproliferative disorder in liver transplant
bit.ly/46TttD9
@theracp.bsky.social
October 20, 2025 at 3:00 AM
IMJ October 2025 #FreeAccess
Original Article: Post-transplant lymphoproliferative disorder in liver transplant
bit.ly/46TttD9
@theracp.bsky.social
Original Article: Post-transplant lymphoproliferative disorder in liver transplant
bit.ly/46TttD9
@theracp.bsky.social
IMJ October 2025 #OpenAccess
Original Article: Point-of-care ultrasound in internal medicine
bit.ly/4nFet2T
@theracp.bsky.social
Original Article: Point-of-care ultrasound in internal medicine
bit.ly/4nFet2T
@theracp.bsky.social
bit.ly
October 19, 2025 at 3:00 AM
IMJ October 2025 #OpenAccess
Original Article: Point-of-care ultrasound in internal medicine
bit.ly/4nFet2T
@theracp.bsky.social
Original Article: Point-of-care ultrasound in internal medicine
bit.ly/4nFet2T
@theracp.bsky.social
IMJ October 2025 #OpenAccess
Original Article: Neurological manifestations of chronic graft versus host disease
bit.ly/48PClfF
@theracp.bsky.social
Original Article: Neurological manifestations of chronic graft versus host disease
bit.ly/48PClfF
@theracp.bsky.social
October 18, 2025 at 3:00 AM
IMJ October 2025 #OpenAccess
Original Article: Neurological manifestations of chronic graft versus host disease
bit.ly/48PClfF
@theracp.bsky.social
Original Article: Neurological manifestations of chronic graft versus host disease
bit.ly/48PClfF
@theracp.bsky.social
IMJ October 2025 #FreeAccess
Original Article: Endoscopy for oesophageal food bolus impactions
bit.ly/3KFXZJl
@theracp.bsky.social
Original Article: Endoscopy for oesophageal food bolus impactions
bit.ly/3KFXZJl
@theracp.bsky.social
October 17, 2025 at 3:00 AM
IMJ October 2025 #FreeAccess
Original Article: Endoscopy for oesophageal food bolus impactions
bit.ly/3KFXZJl
@theracp.bsky.social
Original Article: Endoscopy for oesophageal food bolus impactions
bit.ly/3KFXZJl
@theracp.bsky.social
IMJ October 2025 #OpenAccess
Review: Crisis affecting medical specialist training programmes
bit.ly/42rKbZ5
@theracp.bsky.social
Review: Crisis affecting medical specialist training programmes
bit.ly/42rKbZ5
@theracp.bsky.social
October 16, 2025 at 3:00 AM
IMJ October 2025 #OpenAccess
Review: Crisis affecting medical specialist training programmes
bit.ly/42rKbZ5
@theracp.bsky.social
Review: Crisis affecting medical specialist training programmes
bit.ly/42rKbZ5
@theracp.bsky.social
IMJ October 2025 #FreeAccess
Editorial: A, B, C or D? Goals of Care: a need for a national structural framework.
bit.ly/46JpvOI
@theracp.bsky.social
Editorial: A, B, C or D? Goals of Care: a need for a national structural framework.
bit.ly/46JpvOI
@theracp.bsky.social
October 15, 2025 at 3:01 AM
IMJ October 2025 #FreeAccess
Editorial: A, B, C or D? Goals of Care: a need for a national structural framework.
bit.ly/46JpvOI
@theracp.bsky.social
Editorial: A, B, C or D? Goals of Care: a need for a national structural framework.
bit.ly/46JpvOI
@theracp.bsky.social
IMJ October 2025 #OpenAccess
Editor's Choice (Clinical Perspective): Hyperhidrosis: don’t sweat it
bit.ly/42uVLmg
@theracp.bsky.social
Editor's Choice (Clinical Perspective): Hyperhidrosis: don’t sweat it
bit.ly/42uVLmg
@theracp.bsky.social
October 14, 2025 at 3:00 AM
IMJ October 2025 #OpenAccess
Editor's Choice (Clinical Perspective): Hyperhidrosis: don’t sweat it
bit.ly/42uVLmg
@theracp.bsky.social
Editor's Choice (Clinical Perspective): Hyperhidrosis: don’t sweat it
bit.ly/42uVLmg
@theracp.bsky.social
IMJ October (Vol 55, Iss 10) is now online
bit.ly/42wScMm
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
bit.ly/42wScMm
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
October 13, 2025 at 3:00 AM
IMJ October (Vol 55, Iss 10) is now online
bit.ly/42wScMm
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
bit.ly/42wScMm
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ September 2025 #FreeAccess
Original Article: Lung transplantation for interstitial lung diseases
bit.ly/3JELX2B
@theracp.bsky.social
Original Article: Lung transplantation for interstitial lung diseases
bit.ly/3JELX2B
@theracp.bsky.social
bit.ly
September 18, 2025 at 4:00 AM
IMJ September 2025 #FreeAccess
Original Article: Lung transplantation for interstitial lung diseases
bit.ly/3JELX2B
@theracp.bsky.social
Original Article: Lung transplantation for interstitial lung diseases
bit.ly/3JELX2B
@theracp.bsky.social
IMJ September 2025 #OpenAccess
Original Article: Automatic screening for viral hepatitis in an Emergency Department
bit.ly/46h53EB
@theracp.bsky.social
Original Article: Automatic screening for viral hepatitis in an Emergency Department
bit.ly/46h53EB
@theracp.bsky.social
bit.ly
September 17, 2025 at 4:00 AM
IMJ September 2025 #OpenAccess
Original Article: Automatic screening for viral hepatitis in an Emergency Department
bit.ly/46h53EB
@theracp.bsky.social
Original Article: Automatic screening for viral hepatitis in an Emergency Department
bit.ly/46h53EB
@theracp.bsky.social
IMJ September 2025 #FreeAccess
Original Article: Is incidence and burden of cancer increasing among young individuals?
bit.ly/4p88bdh
@theracp.bsky.social
Original Article: Is incidence and burden of cancer increasing among young individuals?
bit.ly/4p88bdh
@theracp.bsky.social
bit.ly
September 16, 2025 at 4:00 AM
IMJ September 2025 #FreeAccess
Original Article: Is incidence and burden of cancer increasing among young individuals?
bit.ly/4p88bdh
@theracp.bsky.social
Original Article: Is incidence and burden of cancer increasing among young individuals?
bit.ly/4p88bdh
@theracp.bsky.social
IMJ September 2025 #FreeAccess
Original Article: In-hospital cardiac arrest
bit.ly/4p5P8QZ
@theracp.bsky.social
Original Article: In-hospital cardiac arrest
bit.ly/4p5P8QZ
@theracp.bsky.social
September 15, 2025 at 4:01 AM
IMJ September 2025 #FreeAccess
Original Article: In-hospital cardiac arrest
bit.ly/4p5P8QZ
@theracp.bsky.social
Original Article: In-hospital cardiac arrest
bit.ly/4p5P8QZ
@theracp.bsky.social
IMJ September 2025 #FreeAccess
Review: Replacement therapy in congenital adrenal hyperplasia
bit.ly/3HF9KPi
@theracp.bsky.social
Review: Replacement therapy in congenital adrenal hyperplasia
bit.ly/3HF9KPi
@theracp.bsky.social
September 14, 2025 at 4:00 AM
IMJ September 2025 #FreeAccess
Review: Replacement therapy in congenital adrenal hyperplasia
bit.ly/3HF9KPi
@theracp.bsky.social
Review: Replacement therapy in congenital adrenal hyperplasia
bit.ly/3HF9KPi
@theracp.bsky.social
IMJ September 2025 #FreeAccess
Editorial: Addressing medical instability from eating disorders – an urgent call to action
bit.ly/3JN7VQQ
@theracp.bsky.social
Editorial: Addressing medical instability from eating disorders – an urgent call to action
bit.ly/3JN7VQQ
@theracp.bsky.social
bit.ly
September 13, 2025 at 4:00 AM
IMJ September 2025 #FreeAccess
Editorial: Addressing medical instability from eating disorders – an urgent call to action
bit.ly/3JN7VQQ
@theracp.bsky.social
Editorial: Addressing medical instability from eating disorders – an urgent call to action
bit.ly/3JN7VQQ
@theracp.bsky.social
IMJ September 2025 #OpenAccess
Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified?
bit.ly/3K3qDDO
@theracp.bsky.social
Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified?
bit.ly/3K3qDDO
@theracp.bsky.social
bit.ly
September 12, 2025 at 4:00 AM
IMJ September 2025 #OpenAccess
Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified?
bit.ly/3K3qDDO
@theracp.bsky.social
Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified?
bit.ly/3K3qDDO
@theracp.bsky.social
IMJ September (Volume 55, Issue 9) is now online
bit.ly/45ZaKpj
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
bit.ly/45ZaKpj
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
September 11, 2025 at 3:37 AM
IMJ September (Volume 55, Issue 9) is now online
bit.ly/45ZaKpj
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
bit.ly/45ZaKpj
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
The latest IMJ On-Air podcast discusses microbleeds and memory, with geriatric medicine editor Dr Paul Yates and Dr Duncan Austin.
www.racp.edu.au/pomegranate/view/imj-on-air-microbleeds-and-memory
@theracp.bsky.social
www.racp.edu.au/pomegranate/view/imj-on-air-microbleeds-and-memory
@theracp.bsky.social
September 4, 2025 at 4:34 AM
The latest IMJ On-Air podcast discusses microbleeds and memory, with geriatric medicine editor Dr Paul Yates and Dr Duncan Austin.
www.racp.edu.au/pomegranate/view/imj-on-air-microbleeds-and-memory
@theracp.bsky.social
www.racp.edu.au/pomegranate/view/imj-on-air-microbleeds-and-memory
@theracp.bsky.social
IMJ August 2025 #OpenAccess
Viewpoint: Proposing core competencies for physicians in using AI
bit.ly/4lhd9RY
@theracp.bsky.social
Viewpoint: Proposing core competencies for physicians in using AI
bit.ly/4lhd9RY
@theracp.bsky.social
August 22, 2025 at 4:00 AM
IMJ August 2025 #OpenAccess
Viewpoint: Proposing core competencies for physicians in using AI
bit.ly/4lhd9RY
@theracp.bsky.social
Viewpoint: Proposing core competencies for physicians in using AI
bit.ly/4lhd9RY
@theracp.bsky.social
IMJ August 2025 #OpenAccess
Original Article: Hyperuricaemia in Type 1 Gaucher disease
bit.ly/3Hl6zMi
@theracp.bsky.social @marrow.bsky.social
Original Article: Hyperuricaemia in Type 1 Gaucher disease
bit.ly/3Hl6zMi
@theracp.bsky.social @marrow.bsky.social
August 21, 2025 at 4:00 AM
IMJ August 2025 #OpenAccess
Original Article: Hyperuricaemia in Type 1 Gaucher disease
bit.ly/3Hl6zMi
@theracp.bsky.social @marrow.bsky.social
Original Article: Hyperuricaemia in Type 1 Gaucher disease
bit.ly/3Hl6zMi
@theracp.bsky.social @marrow.bsky.social
IMJ August 2025 #OpenAccess
Original Article: The economic burden of sickle cell disease
bit.ly/4mApvG2
@theracp.bsky.social
Original Article: The economic burden of sickle cell disease
bit.ly/4mApvG2
@theracp.bsky.social
August 20, 2025 at 4:00 AM
IMJ August 2025 #OpenAccess
Original Article: The economic burden of sickle cell disease
bit.ly/4mApvG2
@theracp.bsky.social
Original Article: The economic burden of sickle cell disease
bit.ly/4mApvG2
@theracp.bsky.social